Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ilaria Conti
Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients With Advanced and/or Metastatic Cancer
Clinical Pharmacokinetics
Pharmacology
Synthesis of 3-(Imidazo[2,1-B]thiazol-6-Yl)-2h-Chromen-2-One Derivatives and Study of Their Antiviral Activity Against Parvovirus B19
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Related publications
Randomized Phase II Study of the PDGFRα Antibody Olaratumab Plus Liposomal Doxorubicin Versus Liposomal Doxorubicin Alone in Patients With Platinum-Refractory or Platinum-Resistant Advanced Ovarian Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
First-In-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-Her3 Monoclonal Antibody, in Patients With Metastatic or Advanced HER3-Positive Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Avelumab, an Anti-Pd-L1 Antibody, in Patients With Locally Advanced or Metastatic Breast Cancer: A Phase 1b JAVELIN Solid Tumor Study
Breast Cancer Research and Treatment
Cancer Research
Oncology
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Clinical Pharmacokinetics
Pharmacology
Phase 1 Pharmacokinetic Study of MK-0646 (Dalotuzumab), an Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody, in Combination With Cetuximab and Irinotecan in Japanese Patients With Advanced Colorectal Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Complement-Mediated Mechanisms in Anti-Gd2 Monoclonal Antibody Therapy of Murine Metastatic Cancer
Cancer Research
Cancer Research
Oncology
A Phase I First-In-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Rilotumumab Exposure-Response Relationship in Patients With Advanced or Metastatic Gastric Cancer
Clinical Cancer Research
Cancer Research
Oncology
